Ablative Therapy in ARVD and Brugada Syndrome: Is There a role?


Dr Daljeet Kaur Saggu, Hyderabad    19 December 2017

 syndrome, who have recurrent ICD shocks secondary to refractory VT.

2. Substrate-based ablation can be performed in both ARVD and Brugada syndrome, without the need to induce unstable VT in the EP lab.

3. Epicardial ablation, along with endocardial ablation, is frequently required in both these entities.

3. In Brugada syndrome, sodium channel blocker (procainamide/ flecainide) can be used to unmask abnormal areas in some patients.

4. Triggering PVCs, if present in the EP lab, can be targeted for ablation.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.